3983 — China BlueChemical Income Statement
0.000.00%
- HK$10.83bn
- -HK$373.60m
- CNY11.95bn
- 73
- 92
- 93
- 99
Annual income statement for China BlueChemical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 10,417 | 13,398 | 14,279 | 12,990 | 11,946 |
| Cost of Revenue | |||||
| Gross Profit | 1,592 | 2,936 | 2,537 | 2,061 | 1,705 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 9,561 | 11,082 | 12,299 | 10,650 | 10,826 |
| Operating Profit | 857 | 2,316 | 1,980 | 2,340 | 1,121 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,054 | 2,642 | 2,271 | 2,664 | 1,467 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 779 | 1,641 | 1,799 | 2,374 | 1,151 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 745 | 1,498 | 1,643 | 2,382 | 1,071 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 745 | 1,498 | 1,643 | 2,382 | 1,071 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.162 | 0.289 | 0.359 | 0.351 | 0.235 |
| Dividends per Share |